BRIEF published on 04/02/2025 at 07:35, 5 days ago Sensorion nomme Amit Munshi au poste de président du conseil d'administration Conseil D'administration Leadership De Sensorion Nomination D'Amit Munshi Thérapies Contre La Perte Auditive Expérience De Direction En Biotechnologie
BRIEF published on 04/02/2025 at 07:35, 5 days ago Sensorion Appoints Amit Munshi as Chairman of the Board Board Of Directors Hearing Loss Therapies Sensorion Leadership Amit Munshi Appointment Biotech Executive Experience
PRESS RELEASE published on 04/02/2025 at 07:30, 5 days ago Informations privilégiées / Autres communiqués Nomination d’Amit Munshi en tant que Président du Conseil d’Administration chez Sensorion, société de biotechnologie spécialisée dans les thérapies auditives. Annonce du départ de M. Furey Biotechnologie Conseil D'administration Sensorion Thérapies Auditives Amit Munshi
PRESS RELEASE published on 04/02/2025 at 07:30, 5 days ago Inside Information / Other news releases Sensorion appoints Amit Munshi as Chairman of the Board and Independent Director, bringing extensive healthcare industry experience. Munshi to lead innovative therapeutic programs for hearing disorders Chairman Board Sensorion Amit Munshi Hearing Disorders
BRIEF published on 03/26/2025 at 07:35, 12 days ago Sensorion rejoint la conférence Van Lanschot Kempen à Amsterdam Biotechnologie Investisseurs Conference Sensorion Perte Auditive
BRIEF published on 03/26/2025 at 07:35, 12 days ago Sensorion joins the Van Lanschot Kempen conference in Amsterdam Investors Biotechnology Conference Sensorion Hearing Loss
PRESS RELEASE published on 03/26/2025 at 07:30, 12 days ago Inside Information / Other news releases Sensorion announces participation at Van Lanschot Kempen Conference Life Sciences in Amsterdam on April 2-3, 2025. Company focuses on developing therapies for hearing loss disorders Life Sciences Sensorion Amsterdam Hearing Loss Therapies Van Lanschot Kempen Conference
PRESS RELEASE published on 03/26/2025 at 07:30, 12 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence Van Lanschot Kempen dédiée aux sciences de la vie à Amsterdam. La société présente ses thérapies innovantes pour la perte auditive Biotechnologie Conference Sciences De La Vie Sensorion Thérapies Auditives
BRIEF published on 03/14/2025 at 07:35, 24 days ago Sensorion : Bilan 2024 et Perspectives pour 2025 Résultats Financiers Investissements Thérapies Géniques SENS-401 SENS-501
BRIEF published on 03/14/2025 at 07:35, 24 days ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
Published on 04/07/2025 at 00:05, 7 hours 33 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 5 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 07:03, 34 minutes ago Swiss Re to be appointed as co-investment manager of GAM's catastrophe bond and ILS fund range
Published on 04/07/2025 at 07:00, 37 minutes ago Julius Baer further streamlines its organisation to reinforce focus on clients and sustainable growth
Published on 04/06/2025 at 18:20, 13 hours 17 minutes ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 16 hours 28 minutes ago EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 12 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/07/2025 at 07:01, 37 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 37 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 12 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 13 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025